Jacobs Levy Equity Management, Inc Neuro Pace Inc Transaction History
Jacobs Levy Equity Management, Inc
- $24.2 Billion
- Q2 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Neuro Pace Inc stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 51,972 shares of NPCE stock, worth $534,272. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,972
Previous 51,807
0.32%
Holding current value
$534,272
Previous $636,000
9.12%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NPCE
# of Institutions
107Shares Held
21.4MCall Options Held
3.14MPut Options Held
68.6K-
Orbimed Advisors LLC San Diego, CA2.61MShares$26.9 Million1.04% of portfolio
-
Morgan Stanley New York, NY2.59MShares$26.6 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.31MShares$23.8 Million2.0% of portfolio
-
First Light Asset Management, LLC Edina, MN1.38MShares$14.2 Million2.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.37MShares$14.1 Million0.0% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $255M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...